Cardinal Health, Inc.
Location
Ohio
Founded
1979-02-28
Website
Risk Signals
3282 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medical, Dental, and Hospital Equipment and Supplies, Drugs, Drug Proprietaries, and Druggists' Sundries, Management Services), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Cardinal Health, Inc.
Live alerts from global media, monitored by Business Radar
2024-09-20 (modernhealthcare.com)
Cardinal Health to acquire Integrated Oncology Network for $1.1B |
The transaction, subject to regulatory approval, is expected to close later this year, a Cardinal spokesperson said.
Read more
2022-05-25 (bloomberglaw.com)
McKesson, Walgreens, Drug Distributors Dodge Price-Fixing Claims
AmerisourceBergen Corp., Cardinal Health Inc., McKesson Corp., Walgreens Boots Alliance Inc., and other drug distributors Wednesday escaped federal antitrust litigation in Philadelphia over an alleged industry-wide price-fixing scheme by top
Read more
2020-05-15 (inquirer.com)
In Pa. visit, Trump ties coronavirus fight to U.S. factory recovery dreams
In his trip Thursday to a warehouse outside Allentown, President Trump chose to visit a firm positioned to profit from a pandemic. But if PPE-maker Owens & Minor is a model for the future, it’s also an example of the challenges ahead.
Read more
2015-04-21 (cardiovascularbusiness.com)
Cardinal Health settles case over stress test agents for $26.8M
Cardinal Health will pay $26.8 million to settle an antitrust case involving its cardiac perfusion agents and other radiopharmaceuticals, according to the Federal Trade Commission.
Read more
(fiercehealthcare.com)
Anti-monopoly advocates urge FTC to block McKesson, Cardinal Health's big-ticket oncology acquisitions
Anti-monopoly group AELP and others say the vertical integration deals will stamp out competition in already concentrated markets.
Read more